We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Flow Cytometry Rapidly Determines Specific Interleukin-6 Activity

By LabMedica International staff writers
Posted on 29 Oct 2014
Print article
Image: PAR Cyflow-Space Software (Photo courtesy of Sysmex PARTEC)
Image: PAR Cyflow-Space Software (Photo courtesy of Sysmex PARTEC)
The measurement of the specific activity of a given cytokine often requires a time-consuming and tedious bioassay based upon its effect on the proliferation, chemotaxis, or toxicity of a factor-dependent cell line.

The determination of the specific activity of the cytokine interlukin-6 (IL-6) was accomplished by ascertaining the dose–response curve of the phosphorylation of a signaling protein that can be quantified by flow cytometry.

Immunologists at Héma-Québec (Montreal, QC, Canada) used the IL-6 model, as an approach for the determination of the specific activity of cytokines by determining the dose–response curve of the phosphorylation of the signaling protein Stat-3 pY705 for IL-6, in a responsive cell line subjected to different concentrations of the cytokine. The phosphorylation of the protein is quantified by flow cytometry. Since the signaling cascade only takes a few minutes to achieve following linking of the cytokine to its receptor, the whole procedure can be done in a few hours.

The scientists used the cell line 7TD1 (DSMZ, German Collection of Microorganisms and Cell Cultures GmbH; Braunschweig, Germany), which is an IL-6 dependent cell line. The cells were cultured in RPMI-1640 containing 5% fetal bovine serum (FBS) and 10 ng/mL of IL-6. To speed up flow cytometry, the samples were fluorescently barcoded by adding Pacific Blue and Alexa Fluor 488 to allow multiplex analysis. After processing the cells were analyzed on a Partec CyFlow ML flow cytometer (Swedesboro, NJ, USA).

The scientists were able to determine and compare the specific activity of commercial lots of IL-6 using the flow cytometry method. They observed significant differences both from lots from different manufacturers and lots from a same manufacturer, with an eightfold difference between the specific activity of the highest and lowest one. This demonstrated that in studies requiring accurate cytokine concentrations, determining the specific activity for each lot should be a crucial step in order to get reproducible results.

Higher levels of IL-6 have been observed in the blood of advanced or metastatic cancer patients and are associated with the development of encephalitis in children. The study was published on October 5, 2014, in the Journal of Immunological Methods.

Related Links:

Héma-Québec
German Collection of Microorganisms and Cell Cultures GmbH 
Partec


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.